|
English
|
正體中文
|
简体中文
|
Total items :2816861
|
|
Visitors :
27618340
Online Users :
614
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
|
|
|
|
Taiwan Academic Institutional Repository >
Browse by Author
|
"tabak f"
Showing items 1-3 of 3 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 臺大學術典藏 |
2021-09-04T06:11:25Z |
Alisporivir with peginterferon/ribavirin in patients with chronic hepatitis C genotype 1 infection who failed to respond to or relapsed after prior interferon-based therapy: FUNDAMENTAL, a Phase II trial
|
Buti M.; Flisiak R.; JIA-HORNG KAO; Chuang W.-L.; Streinu-Cercel A.; Tabak F.; Calistru P.; Goeser T.; Rasenack J.; Horban A.; Davis G.L.; Alberti A.; Mazzella G.; Pol S.; Orsenigo R.; Brass C. |
| 臺大學術典藏 |
2018-09-10T15:24:48Z |
Alisporivir with peginterferon/ribavirin in patients with chronic hepatitis C genotype 1 infection who failed to respond to or relapsed after prior interferon-based therapy: FUNDAMENTAL, a Phase II trial
|
Buti, M.;Flisiak, R.;Kao, J.-H.;Chuang, W.-L.;Streinu-Cercel, A.;Tabak, F.;Calistru, P.;Goeser, T.;Rasenack, J.;Horban, A.;Davis, G.L.;Alberti, A.;Mazzella, G.;Pol, S.;Orsenigo, R.;Brass, C.; JIA-HORNG KAO |
| 國立臺灣大學 |
2013 |
ALISPORIVIR (ALV) PLUS PEGINTERFERON/RIBAVIRIN (PR) ACHIEVES HIGH SVR12 RATES AMONG NULL RESPONDERS, IL28BCT/TT AND CIRRHOTIC HCVG1 PATIENTS (FUNDAMENTAL STUDY INTERIM ANALYSIS)
|
Buti, M.; Flisiak, R.; Rasenack, J.; Davis, G.; Alberti, A.; Goeser, T.; Stanciu, C.; Chuang, W. -L.; Tabak, F.; Kao, J. -H.; Streinu-Cercel, A.; Hofstetter, G.; Wang, J.; Avila, C.; Orsenigo, R.; 高嘉宏 |
Showing items 1-3 of 3 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
